HiberCell commences Phase Ia/b trial of HC-7366 for solid tu

HiberCell has commenced a first-in-human Phase Ia/b clinical trial of HC-7366 to treat advanced solid tumour patients.

Related Keywords

Tennessee , United States , Alan Rigby , Centric Services For , Sarah Cannon Research Institute , Tennessee Oncology , General Control Nonderepressible , Investigational New Drug , Preference Management Solution , Centric Services , Alternate Site Clinical Trials ,